Evidence map›Paper›PMID 35082556›Full record

ArticleContrast media & molecular imaging2022

The Diagnostic Value of

Jun Liu, Cuicui Li, Xu Yang, Xia Lu, Mingyu Zhang, Luodan Qian, Wei Wang, Ying Kan, Jigang Yang

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. The value ofQuantitative imaging in medicine and surgery · 2025
    Article
  2. Quantitative imaging in medicine and surgery · 2024
    Article
  3. Insights into imaging · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jun LiuDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0002-1907-8989
Cuicui LiDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0002-0077-727X
Xu YangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0001-7488-963X
Xia LuDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0003-2574-2281
Mingyu ZhangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0003-0658-8493
Luodan QianDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0001-9526-5172
Wei WangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0001-8990-5516
Ying KanDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0001-8115-6071
Jigang YangDepartment of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0002-0538-7676
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To explore the diagnostic value of Methods: Ninety-eight NB patients were enrolled in BMI analysis. Four patterns of bone marrow uptake were categorized based on pretreatment Results: BMUP had excellent consistency among different physicians. Kappa coefficients of two residents and two attending physicians and between the resident and attending physician, were 0.857, 0.891, and 0.845, respectively. The optimal cut-off value of SUVmax-Bone/Liver was 2.08 to diagnose BMI for BMUP3 patients, and the area under curve (AUC) was 0.873. AUC of PHOX2B of bone marrow (PHOX2B of BM), PHOX2B of blood, BMB, and Conclusions: BMUP of pretreatment

Indexed as

Fluorodeoxyglucose F18NeuroblastomaBone MarrowChildHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID35082556
PMCPMC8758298
OpenAlexW4206166388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.